Across TCGA pan-cancer cohorts, LINC00370 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated LINC00370 data layer.
The strongest signal is observed in lung adenocarcinoma (LUAD), where higher LINC00370 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC00370 expression acts as an unfavorable survival marker, although some lineages such as LAML and CESC show a favorable association.
LUAD, COAD, and MESO are the cancer types where LINC00370 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.